Peter Selby – författare

This new edition of Introduction to the Cellular and Molecular Biology of Cancer provides a comprehensive overview of cancer biology, covering the current status of both research and treatment. For the student or new researcher the breadth of cancer research can appear daunting, yet a broad understanding is essential for translation of laboratory findings into the clinic. Within the broad scope of the book, each topic is reviewed authoritatively by experts in the field, and the accompanying bibliographies allow rapid access to the relevant current literature. The book covers topics extending from the molecular alterations found in cancer cells and their causes to the current range of approaches to treatment. Since the publication of the previous edition in 1997 there has been unprecedented progress in cancer research: this is reflected by an extensive revision of all the material, and the addition of eight new chapters, covering DNA repair, epigenetic events, the cell cycle, cell immortalisation, apoptosis, angiogenesis, animal models, the genome, transcriptome and proteome, radiotherapy and molecular radiotherapy, immunotherapy, and gene therapy.The fourth edition of this popular book will serve as a text for both undergraduate and postgraduate use and also as an introduction for clinicians and scientists new to the field.

This new edition of Introduction to the Cellular and Molecular Biology of Cancer provides a concise yet comprehensive overview of cancer biology, covering the current status of both research and treatment. For the student or new researcher the breadth of cancer research can appear daunting, yet a broad understanding is essential for translation of laboratory findings into the clinic. Within the broad scope of the book, each topic is reviewed authoritatively by experts in the field, and the accompanying bibliographies allow rapid access to the relevant current literature. The book covers topics extending from the molecular alterations found in cancer cells and their causes to the current range of approaches to treatment. Since the publication of the previous edition in 1997 there has been unprecedented progress in cancer research:

There have been impressive improvements in the diagnosis and treatment of cancer in recent decades. In economically advantaged countries with well-developed healthcare systems over 50% of all cancer patients achieve long term survival and are probably cured. Not only has survival improved radically for cancer patients but also there has been an increasing focus on the quality of patient's lives, on improving the patient experience of care and on developing effective support for the very many cancer survivors. Despite the progress in cancer treatment, unfortunately a substantial number of cancer patients will still ultimately die of their disease. For many this will follow periods of successful treatment which results in good remissions and good quality of life. Helping patients to make the right choices about their care towards the end of their lives is one of the greatest and most challenging responsibilities of all healthcare professionals.Legal change on the provision of assisted dying by healthcare professionals has occurred in a substantial number of jurisdictions. This work brings together contributions on end of life choices from experienced professionals from oncology disciplines, palliative care, law, nurses and professions allied to medicine. The goals are:*To better inform cancer care professionals and the wider community about developments in choices in end of life care for cancer patients internationally. *To better answer questions from patients and respond to requests from patients, including questions about and requests for assisted dying in countries where it is legal to do so. *To have a balanced and well informed dialogue about choices available to patients without developing a formal policy position on change in law.*To provide a basis of information for future educational activities.

Cancer treatment has advanced remarkably, offering hope andextending life for many. But with these advances, clinicians and policymakersare increasingly faced with the complex and challenging questions surroundingend-of-life care. How can we ensure the highest quality of life for patientswith relapsed disease? What does a well-informed dialogue on assisted dyinglook like, and who should guide it?For healthcare professionals, legislators, and the widerpublic, navigating these choices requires the most current and accurateinformation. The updated edition of a previous volume End of Life Choicesfor Cancer Patients provides a crucial resource for this evolvinglandscape.Building on the 2020 edition, this book assembles amulti-professional team of contributors-experts in oncology, palliative care,law, and allied health professions. They offer a balanced, evidence-basedexploration of modern end-of-life care, focusing on patient needs,international developments, and the far-reaching implications of legislativechange.Inside, you will find:* Updated information and insights reflectingrecent parliamentary considerations on Assisted Dying in the UK.* An exploration of the multifacetedresponsibilities of healthcare professionals in guiding patients throughdifficult end-of-life decisions.* A clear distinction between the roles of medicalexpertise and social opinion in shaping public policy on assisted dying, asdefined by a 2019 expert workshop.* Context for legislative debates, equippingprofessionals and the public with the facts needed for a balanced and informeddiscussion.This is more than a book; it is an essential tool forprofessional colleagues, legislators, and concerned citizens alike, offeringclarity and support in one of the most challenging areas of modern medicine.This guide will ensure your practice, your policies, and your understanding aregrounded in the latest evidence.